药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Dicyclomine
Geranylgeranyl diphosphate
The risk or severity of QTc prolongation can be increased when Geranylgeranyl diphosphate is combined with Propafenone.
Dicyclomine
Farnesyl diphosphate
The risk or severity of QTc prolongation can be increased when Farnesyl diphosphate is combined with Propafenone.
Dicyclomine
Triptorelin
The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Propafenone.
Dicyclomine
Histrelin
The risk or severity of QTc prolongation can be increased when Histrelin is combined with Propafenone.
Dicyclomine
Buserelin
The risk or severity of QTc prolongation can be increased when Buserelin is combined with Propafenone.
Dicyclomine
Degarelix
The risk or severity of QTc prolongation can be increased when Degarelix is combined with Propafenone.
Dicyclomine
Pasireotide
The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Propafenone.
Dicyclomine
Amisulpride
The risk or severity of QTc prolongation can be increased when Amisulpride is combined with Propafenone.
Dicyclomine
Levocetirizine
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Propafenone.
Dicyclomine
Tandutinib
The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Propafenone.
Dicyclomine
Ezogabine
The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Propafenone.
Dicyclomine
Farnesyl thiopyrophosphate
The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Propafenone.
Dicyclomine
Fleroxacin
The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Propafenone.
Dicyclomine
Vorinostat
The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Propafenone.
Dicyclomine
Pheniramine
The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Propafenone.
Dicyclomine
Lapatinib
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Propafenone.
Dicyclomine
Chlorprothixene
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Propafenone.
Dicyclomine
Sevoflurane
The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Propafenone.
Dicyclomine
Desflurane
The risk or severity of QTc prolongation can be increased when Desflurane is combined with Propafenone.
Dicyclomine
Cyclizine
The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Propafenone.